Bioharvest Sciences Inc (BHST) Stock Price, Quote & News

Company Profile

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and function...

Industry: Packaged Foods

Sector: Consumer Defensive

Phone: 604 689 5722

Fax: 604 685 9182

Website: www.bioharvest.com

Address:

1140-625 Howe Street, Vancouver, Canada

sepsis74 Mar. 31 at 10:23 PM

$BHST So typical. Management apparently had a bigger, better idea that will require more investment and more delayed gratification. Did they actually say whether or not they will need to raise more money?

0 · Reply

BioHarvest_Sciences Mar. 31 at 9:50 PM

$BHST News Release --> BioHarvest Sciences Announces First-Ever Successful Stable Cell Culture Development of Rare Fragrance-Producing Plant Using Proprietary Botanical Synthesis Platform Read full release: https://ir.bioharvest.com/news/default.aspx

0 · Reply

newsfile_corp Mar. 31 at 8:03 PM

https://nfne.ws/290705 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #Earnings #QuarterlyResult

0 · Reply

newsfile_corp Mar. 31 at 12:00 PM

https://nfne.ws/290629 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #NASDAQ #Investing

0 · Reply

forgottenchuck Mar. 30 at 5:48 PM

$BHST earnings report out tommorrow, should be interesting

0 · Reply

BioHarvest_Sciences Mar. 26 at 3:11 PM

$BHST News Release--> BioHarvest Sciences Announces that VINIA is now the No.1 Resveratrol Polyphenol Brand in the United States. Read news release: https://bit.ly/4bJok2Z “Achieving the No.1 position in the U.S. resveratrol category in less than five years reflects both the strength of VINIA and the power of our Botanical Synthesis platform technology,” said Ilan Sobel, CEO.

0 · Reply

newsfile_corp Mar. 26 at 11:31 AM

https://nfne.ws/290040 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #NASDAQ #Investing

0 · Reply

forgottenchuck Mar. 25 at 3:15 AM

$BHST did anybody listen to the webinar tonight on the vinia blood flow hydration challenge. it comes on every tuesday night at 8pm eastern time. a nutritionist host it and the ceo was in tonight. very interesting call

0 · Reply

OfficialStocktwitsUser Mar. 20 at 7:42 PM

$BHST RSI: 43.38, MACD: -0.1213 Vol: 0.21, MA20: 4.40, MA50: 4.72 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

BioHarvest_Sciences Mar. 17 at 2:28 PM

$BHST News Release--> BioHarvest Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the results, provide an update on business operations, and host an analyst Q+A. Read release: https://bit.ly/4uApPZQ Register for webcast: https://bit.ly/4lvCut0News Release-

0 · Reply

BioHarvest Sciences Reports Fourth Quarter and Full-Year 2025 Financial Results

Mar 31, 2026, 8:00 AM EDT - 13 days ago

BioHarvest Sciences Announces First-Ever Successful Stable Cell Culture Development of Rare Fragrance-Producing Plant Using Proprietary Botanical Synthesis Platform

Mar 26, 2026, 7:30 AM EDT - 18 days ago

BioHarvest Sciences Announces that VINIA is Now the No.1 Resveratrol Polyphenol Brand in the United States

Mar 17, 2026, 8:30 AM EDT - 27 days ago

BioHarvest Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026

Mar 13, 2026, 4:53 PM EDT - 4 weeks ago

BioHarvest Sciences Announces Grant of Long-Term Incentive Awards to Employees, Officers and Directors

Mar 5, 2026, 7:30 AM EST - 5 weeks ago

BioHarvest Sciences Announces Board Transition and Appointment of Prof. Hezi Levy

Mar 3, 2026, 8:30 AM EST - 5 weeks ago

BioHarvest Sciences to Participate in 38th Annual Roth Conference on March 22-24, 2026

Jan 7, 2026, 7:30 AM EST - 3 months ago

BioHarvest Sciences Issues Year End Shareholder Letter

Dec 18, 2025, 7:30 AM EST - 4 months ago

BioHarvest Sciences Awarded $1.6 Million USD Grant from the Israeli Innovation Authority to Advance Second-Generation Botanical Synthesis Platform

Dec 3, 2025, 7:30 AM EST - 4 months ago

BioHarvest Sciences Announces Launch of VINIA Blood Flow Hydration Product

Nov 13, 2025, 4:05 PM EST - 5 months ago

BioHarvest Sciences Reports Third Quarter 2025 Financial Results

Nov 12, 2025, 8:42 AM EST - 5 months ago

BioHarvest Sciences to Attend the Craig-Hallum 16th Annual Alpha Select Conference on November 18, 2025

Nov 10, 2025, 4:18 PM EST - 5 months ago

BioHarvest Sciences Announces Closing of $19.9 Million Upsized Public Offering of Common Stock and Exercise of Underwriter's Option to Purchase Additional Shares

Nov 7, 2025, 7:30 AM EST - 5 months ago

BioHarvest Sciences Announces Pricing of $17.4 Million Upsized Public Offering of Common Stock

Nov 6, 2025, 4:37 PM EST - 5 months ago

BioHarvest Announces Proposed Public Offering of Common Stock

Nov 4, 2025, 7:30 AM EST - 5 months ago

BioHarvest Sciences to Host Third Quarter Earnings Call on November 13 at 4:30 p.m. Eastern Time

Oct 30, 2025, 7:30 AM EDT - 5 months ago

BioHarvest Sciences Announces Strategic CDMO Partnership to Revolutionize Saffron Compound Production with Botanical Synthesis

Sep 22, 2025, 6:32 AM EDT - 7 months ago

BioHarvest Sciences Strengthens Balance Sheet by $14.7 Million with Injection of $10.9 Million Gross Proceeds and Additional $3.8 Million in Debt Reduction

Sep 10, 2025, 7:00 AM EDT - 7 months ago

BioHarvest Sciences Announces Breakthrough in Botanical Synthesis Capabilities with Plant-Based Exosome Production at Scale

Sep 2, 2025, 8:30 AM EDT - 7 months ago

BioHarvest Sciences to Host a Virtual Investor Webinar on September 10, 2025 at 1:00 PM ET

Aug 11, 2025, 7:30 AM EDT - 8 months ago

BioHarvest Sciences Reports Second Quarter 2025 Financial Results

Aug 4, 2025, 8:30 AM EDT - 9 months ago

BioHarvest Sciences to Host Second Quarter 2025 Earnings Call on August 11 at 8:00 a.m. Eastern Time

Jul 23, 2025, 8:30 AM EDT - 9 months ago

BioHarvest Sciences to Present at Canaccord Genuity 45th Annual Growth Conference on August 12-14, 2025

Jun 4, 2025, 7:00 AM EDT - 11 months ago

BioHarvest Launches Informed Sport-Certified VINIA DailyChews 2X Formula for Athletes and People with Active Lifestyles

May 21, 2025, 8:30 AM EDT - 11 months ago

BioHarvest Secures New CDMO Contract to Develop Plant-based Fragrance Compound

May 15, 2025, 4:05 PM EDT - 11 months ago

BioHarvest Sciences Reports First Quarter 2025 Financial Results

May 12, 2025, 8:30 AM EDT - 1 year ago

BioHarvest Announces Completion of Stage 1 Development for CDMO Contract with Nasdaq-Listed Pharmaceutical Company

May 1, 2025, 8:30 AM EDT - 1 year ago

BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time

Mar 31, 2025, 4:05 PM EDT - 1 year ago

BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 17, 2025, 8:30 AM EDT - 1 year ago

BioHarvest Sciences to Host Fourth Quarter and Full Year 2024 Earnings Call on March 31 at 4:30 p.m. Eastern Time

Mar 6, 2025, 8:30 AM EST - 1 year ago

BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025

Mar 4, 2025, 8:30 AM EST - 1 year ago

BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells

Feb 18, 2025, 8:30 AM EST - 1 year ago

BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD

Feb 12, 2025, 8:30 AM EST - 1 year ago

BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar on February 18

Jan 22, 2025, 8:30 AM EST - 1 year ago

BioHarvest Announces Appointment of Sharon Malka to Board of Directors

Jan 8, 2025, 8:41 AM EST - 1 year ago

BioHarvest Issues Shareholder Letter and Provides Corporate Update

Dec 11, 2024, 6:00 AM EST - 1 year ago

Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of Ingredients Through Botanical Synthesis Technology

Nov 25, 2024, 4:05 PM EST - 1 year ago

BioHarvest Sciences Reports Third Quarter 2024 Financial Results

Nov 25, 2024, 8:30 AM EST - 1 year ago

BioHarvest Launches VINIA SuperFood Functional Tea Line

Nov 21, 2024, 8:30 AM EST - 1 year ago

BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024

Nov 18, 2024, 8:30 AM EST - 1 year ago

BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 P.M. Eastern Time

Nov 12, 2024, 8:30 AM EST - 1 year ago

BioHarvest Sciences Begins Trading on the Nasdaq Global Market

Nov 7, 2024, 8:30 AM EST - 1 year ago

BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market

Oct 23, 2024, 8:30 AM EDT - 1 year ago

BioHarvest Sciences Announces Record Preliminary Third Quarter 2024 Financial Results

Oct 16, 2024, 8:47 AM EDT - 1 year ago

BioHarvest Sciences to Participate in LD Micro Main Event XVII Conference on October 30, 2024

Sep 20, 2024, 8:30 AM EDT - 1 year ago

BioHarvest Sciences Reports Director's Ongoing Key Role Following Resignation from Board

Sep 12, 2024, 8:30 AM EDT - 1 year ago

BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on September 24-25, 2024

Sep 4, 2024, 8:30 AM EDT - 1 year ago

BioHarvest Sciences to Present at H.C. Wainwright 26th Annual Global Investment Conference

Aug 29, 2024, 9:22 AM EDT - 1 year ago

BioHarvest Sciences Reports Record Second Quarter 2024 Financial Results

Aug 28, 2024, 9:56 AM EDT - 1 year ago

BioHarvest Sciences Surpasses USD $1.0 Million in Cumulative Direct Sales of Coffee with VINIA Inside

sepsis74 Mar. 31 at 10:23 PM

0 · Reply

BioHarvest_Sciences Mar. 31 at 9:50 PM

0 · Reply

newsfile_corp Mar. 31 at 8:03 PM

https://nfne.ws/290705 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #Earnings #QuarterlyResult

0 · Reply

newsfile_corp Mar. 31 at 12:00 PM

https://nfne.ws/290629 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #NASDAQ #Investing

0 · Reply

forgottenchuck Mar. 30 at 5:48 PM

$BHST earnings report out tommorrow, should be interesting

0 · Reply

BioHarvest_Sciences Mar. 26 at 3:11 PM

0 · Reply

newsfile_corp Mar. 26 at 11:31 AM

https://nfne.ws/290040 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #NASDAQ #Investing

0 · Reply

forgottenchuck Mar. 25 at 3:15 AM

0 · Reply

OfficialStocktwitsUser Mar. 20 at 7:42 PM

0 · Reply

BioHarvest_Sciences Mar. 17 at 2:28 PM

0 · Reply

newsfile_corp Mar. 17 at 12:32 PM

https://nfne.ws/288805 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #Earnings #QuarterlyResult

0 · Reply

mankind1 Mar. 9 at 7:16 PM

$BHST this needs some type of organic endorsement.

0 · Reply

BillionerOfKing Mar. 7 at 3:32 AM

$BHST Current Stock Price: $4.23

0 · Reply

sepsis74 Mar. 5 at 9:21 PM

$BHST OK, it's obvious someone with a huge position has been selling their position for a couple of months.

0 · Reply

newsfile_corp Mar. 5 at 12:31 PM

https://nfne.ws/286354 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #Appointment #NASDAQ #Inve

0 · Reply

BioHarvest_Sciences Mar. 3 at 8:27 PM

$BHST News Release--> BioHarvest Sciences to Participate in 38th Annual Roth Conference on March 22-24, 2026. CEO Ilan Sobel will attend and host 1x1 investor meetings throughout the event. Read March 3, 2026 news release: http://bit.ly/4r7dn0K

0 · Reply

newsfile_corp Mar. 3 at 1:31 PM

https://nfne.ws/286091 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #NASDAQ #Investing

0 · Reply

OfficialStocktwitsUser Feb. 27 at 11:26 PM

$BHST RSI: 47.10, MACD: -0.1289 Vol: 0.13, MA20: 4.72, MA50: 5.02 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

forgottenchuck Feb. 26 at 7:06 PM

$BHST when does bioharvest report earnings?

1 · Reply

BioHarvest_Sciences Feb. 19 at 4:59 PM

$BHST Roth Capital initiates Analyst coverage of BioHarvest Sciences (BHST) https://investing.com/news/analyst-ratings/rothmkm-initiates-bioharvest-sciences-stock-with-buy-rating-93CH-4512648

0 · Reply

erevnon Feb. 19 at 11:45 AM

Roth Capital initiates coverage on BioHarvest Sciences $BHST at Buy rating and announces a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

VolumeChaser Feb. 18 at 9:24 AM

$BHST Speculative structure where corporate actions drive valuation more than operations.

0 · Reply

Market Cap	84.55M
Revenue (ttm)	34.51M
Net Income (ttm)	-11.14M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-32.28%
Debt to Equity Ratio	0.10

Volume	11,200
Avg Vol	23,906
Day's Range	N/A - N/A
Shares Out	19.62M
Stochastic %K	8%
Beta	1.16
Analysts	Strong Sell
Price Target	$12.75